If the product is good, I think CRs actually give the company exposure to new investors.
Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-372
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.020(3.45%) |
Mkt cap ! $63.96M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 58.0¢ | 56.0¢ | $4.235K | 7.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 20712 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 13110 | 1 |
View Market Depth
| Last trade - 10.10am 15/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |